Merger Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies is Fair to Shareholders – LPT, CISN, IPHS, ACHN

Monday, 04. November 2019 22:04

NEW YORK, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Liberty Property Trust (NYSE: LPT)
The investigation concerns whether Liberty and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Liberty to Prologis, Inc. for 0.675x of a Prologis share for each Liberty share. If you are a Liberty shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/liberty-property-trust-lpt-prologis-stock-merger/.

Cision Ltd. (NYSE: CISN)
The investigation concerns whether Cision and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Cision to an affiliate of Platinum Equity for $10.00 per share. If you are a Cision shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/cision-ltd-cisn-stock-merger-platinum-equity/.

Innophos Holdings, Inc. (NASDAQ: IPHS)
The investigation concerns whether Innophos and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Innophos to an affiliate of One Rock Capital Partners, LLC for $32.00 per share. If you are an Innophos shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/innophos-holdings-inc-iphs-stock-merger-one-rock/.

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN)
The investigation concerns whether Achillion and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Achillion to Alexion Pharmaceuticals, Inc. If you are an Achillion shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/achillion-pharmaceuticals-inc-alexion-stock-merger/.

On behalf of shareholders of these companies, Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Primary Logo

Related Links: 
Author:
Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.